David Andrew Mitchell
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
David Andrew Mitchell has a total of 289 co-authors. Here are the top co-authors by number of shared publications:
- Thomas Mücke
Department of Oral and Maxillofacial Surgery, Malteser Kliniken Rhein-Ruhr, Krefeld-Uerdingen, Germany
39 shared publications Klaus-Dietrich Wolff
Department of Oral and Maxillofacial Surgery, Technische Universität München, Klinikum rechts der Isar, Munich, Germany
27 shared publications- Anastasios Kanatas
St James Institute of Oncology, Leeds Dental Institute, Leeds General Infirmary and University of Leeds, United Kingdom
15 shared publications Anastasios Kanatas
Department of Oral and Maxillofacial Surgery, Technische Universität München, Klinikum Rechts der Isar, München, Germany
13 shared publicationsAndrea Rau
Department of Oral and Maxillofacial Surgery, Technische Universität München, Klinikum Rechts der Isar, München, Germany
10 shared publicationsStefan Wagenpfeil
Department of Oral and Maxillofacial Surgery, Technische Universität München, Klinikum rechts der Isar, Munich, Germany
10 shared publications
Latest Publications
- 27 February 2020
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 45 (5) , 368-369
Case Report 18F-FDG PET/CT of Pseudomyogenic Hemangioendothelioma
Hemangioendotheliomas are a heterogeneous group of vascular neoplasm that may affect the liver, bone, and soft tissues. Among its variants, pseudomyogenic hemangioendothelioma is rarely encountered. Pseudomyogenic hemangioendothelioma is usually characterized by multiple soft tissue lesions, with occasional bone lesions. Fewer than 20 cases with exclusive involvement of bone structures have been reported. We describe a case of pseudomyogenic hemangioendothelioma involving multiple bony structures but without soft tissue involvement in a 7-year-old girl, imaged with 18F-FDG PET/CT at diagnosis and during treatment with mammalian target of rapamycin inhibitors.
- 27 February 2020
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 45 (5) , 368-369
Case Report 18F-FDG PET/CT of Pseudomyogenic Hemangioendothelioma
Hemangioendotheliomas are a heterogeneous group of vascular neoplasm that may affect the liver, bone, and soft tissues. Among its variants, pseudomyogenic hemangioendothelioma is rarely encountered. Pseudomyogenic hemangioendothelioma is usually characterized by multiple soft tissue lesions, with occasional bone lesions. Fewer than 20 cases with exclusive involvement of bone structures have been reported. We describe a case of pseudomyogenic hemangioendothelioma involving multiple bony structures but without soft tissue involvement in a 7-year-old girl, imaged with 18F-FDG PET/CT at diagnosis and during treatment with mammalian target of rapamycin inhibitors.
- 1 January 2019
- Published by Elsevier in British Journal of Oral and Maxillofacial Surgery
- Vol. 57 (1) , 67-71
Simulation-based training in maxillofacial surgery: are we going to be left behind?
- 1 January 2019
- Published by Elsevier in British Journal of Oral and Maxillofacial Surgery
- Vol. 57 (1) , 67-71
Simulation-based training in maxillofacial surgery: are we going to be left behind?
- Open Access
- 1 November 2018
- Published by Elsevier in British Journal of Oral and Maxillofacial Surgery
- Vol. 56 (9) , 777-778
Genomic mutations and proof of causation between dysplasia and squamous cell carcinoma in medicolegal cases: a useful approach or a waste of resources?
- 1 November 2018
- Published by Elsevier in British Journal of Oral and Maxillofacial Surgery
- Vol. 56 (9) , 777-778
Open AccessGenomic mutations and proof of causation between dysplasia and squamous cell carcinoma in medicolegal cases: a useful approach or a waste of resources?
- 1 November 2018
- Published by Elsevier in British Journal of Oral and Maxillofacial Surgery
- Vol. 56 (9) , 820-829
Margins and survival in oral cancer
- 1 November 2018
- Published by Elsevier in British Journal of Oral and Maxillofacial Surgery
- Vol. 56 (9) , 820-829
Margins and survival in oral cancer
- Open Access
- 1 September 2018
- Published by Elsevier in British Journal of Oral and Maxillofacial Surgery
- Vol. 56 (7) , 571-572
Cadaveric dissection in oral and maxillofacial surgery: is it time for a new approach?
- 1 September 2018
- Published by Elsevier in British Journal of Oral and Maxillofacial Surgery
- Vol. 56 (7) , 571-572
Open AccessCadaveric dissection in oral and maxillofacial surgery: is it time for a new approach?
- Open Access
- 1 April 2018
- Published by Elsevier in British Journal of Oral and Maxillofacial Surgery
- Vol. 56 (3) , 240
Corrigendum to “Medial approach for minimally-invasive harvesting of a deep circumflex iliac artery flap for reconstruction of the jaw using virtual surgical planning and CAD/CAM technology” [Br J Oral Maxillofac Surg 2017;55(November (9)):946–51]
- 1 April 2018
- Published by Elsevier in British Journal of Oral and Maxillofacial Surgery
- Vol. 56 (3) , 240
Open AccessCorrigendum to “Medial approach for minimally-invasive harvesting of a deep circumflex iliac artery flap for reconstruction of the jaw using virtual surgical planning and CAD/CAM technology” [Br J Oral Maxillofac Surg 2017;55(November (9)):946–51]
- 19 October 2017
- Published by Elsevier in British Journal of Oral and Maxillofacial Surgery
- Vol. 55 (9) , 989
Book review
- 19 October 2017
- Published by Elsevier in British Journal of Oral and Maxillofacial Surgery
- Vol. 55 (9) , 989
Book review
- Open Access
- 17 June 2017
- Published by Elsevier in British Journal of Oral and Maxillofacial Surgery
- Vol. 55 (7) , 752-753
Why don’t we mention “impact on intimacy” when we ask patients to give consent for treatment of oral cancer?
- 17 June 2017
- Published by Elsevier in British Journal of Oral and Maxillofacial Surgery
- Vol. 55 (7) , 752-753
Open AccessWhy don’t we mention “impact on intimacy” when we ask patients to give consent for treatment of oral cancer?